CD8+ Tregs from patients with active SLE failed to suppress effector T cells, while CD8+ Tregs from patients with inactive SLE demonstrated comparable suppressive ability as those from healthy individuals [65]. The gene discussed is CD8A; the disease is systemic lupus erythematosus.